Anthem Bioscienc

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0CZ201020
  • NSEID: ANTHEM
  • BSEID: 544449
INR
950.95
13.2 (1.41%)
BSENSE

Nov 20

BSE+NSE Vol: 3.82 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
594.03
418.22
610.94
423.15
550.03
540.21
483.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
594.03
418.22
610.94
423.15
550.03
540.21
483.20
Raw Material Cost
200.77
148.56
165.20
184.92
201.26
162.21
183.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-16.09
-2.36
50.25
-42.33
22.10
68.67
-6.72
Employee Cost
81.25
78.84
72.48
70.48
67.72
72.03
59.78
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
56.61
42.61
55.79
52.89
41.04
45.80
51.38
Total Expenditure (Excl Depreciation)
322.54
267.65
343.73
265.96
332.12
348.71
288.01
Operating Profit (PBDIT) excl Other Income
271.49
150.57
267.21
157.19
217.91
191.50
195.19
Other Income
58.90
24.89
51.21
33.53
48.23
22.81
14.06
Operating Profit (PBDIT)
330.39
175.46
318.42
190.72
266.14
214.31
209.25
Interest
3.31
0.89
1.90
0.35
3.03
1.61
0.52
Exceptional Items
0.00
0.00
0.98
-25.37
0.00
0.00
0.00
Gross Profit (PBDT)
327.08
174.57
317.50
165.00
263.11
212.70
208.73
Depreciation
30.71
29.99
39.59
34.53
33.50
26.45
30.42
Profit Before Tax
296.37
144.58
277.92
130.47
229.60
186.25
178.31
Tax
84.91
24.64
88.16
37.66
56.17
50.46
95.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
211.46
119.94
189.76
92.82
173.43
135.79
82.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
211.46
119.94
189.76
92.82
173.43
135.79
82.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
211.46
119.94
189.76
92.82
173.43
135.79
82.62
Equity Capital
112.71
112.68
112.34
112.32
112.32
112.32
111.82
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.75
2.13
3.38
1.65
3.09
2.42
1.48
Diluted Earnings per share
3.72
2.11
3.34
1.64
3.09
2.42
1.47
Operating Profit Margin (Excl OI)
45.7%
36.0%
43.74%
37.15%
39.62%
35.45%
40.4%
Gross Profit Margin
55.06%
41.74%
51.97%
38.99%
47.84%
39.37%
43.2%
PAT Margin
35.6%
28.68%
31.06%
21.94%
31.53%
25.14%
17.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 42.04% vs -31.54% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 76.30% vs -36.79% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 80.31% vs -43.65% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 271.91% vs -53.16% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Anthem Bioscienc With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
594.03
1,833.59
-1,239.56
-67.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
594.03
1,833.59
-1,239.56
-67.60%
Raw Material Cost
200.77
640.75
-439.98
-68.67%
Purchase of Finished goods
0.00
3.14
-3.14
-100.00%
(Increase) / Decrease In Stocks
-16.09
25.93
-42.02
-162.05%
Employee Cost
81.25
411.51
-330.26
-80.26%
Power Cost
0.00
59.94
-59.94
-100.00%
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
56.61
208.29
-151.68
-72.82%
Total Expenditure (Excl Depreciation)
322.54
1,349.55
-1,027.01
-76.10%
Operating Profit (PBDIT) excl Other Income
271.49
484.04
-212.55
-43.91%
Other Income
58.90
69.05
-10.15
-14.70%
Operating Profit (PBDIT)
330.39
553.09
-222.70
-40.26%
Interest
3.31
7.14
-3.83
-53.64%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
327.08
545.95
-218.87
-40.09%
Depreciation
30.71
115.01
-84.30
-73.30%
Profit Before Tax
296.37
430.94
-134.57
-31.23%
Tax
84.91
140.19
-55.28
-39.43%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
211.46
290.76
-79.30
-27.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
211.46
290.76
-79.30
-27.27%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
211.46
290.76
-79.30
-27.27%
Equity Capital
112.71
16.50
96.21
583.09%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.75
17.62
-13.87
-78.72%
Diluted Earnings per share
3.72
17.62
-13.90
-78.89%
Operating Profit Margin (Excl OI)
45.70%
26.40%
0.00
19.30%
Gross Profit Margin
55.06%
29.77%
0.00
25.29%
PAT Margin
35.60%
15.86%
0.00
19.74%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 594.03 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 42.04% vs -31.54% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 8.00% vs 4.78% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 211.46 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 76.30% vs -36.79% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 21.93% vs 7.10% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 271.49 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 80.31% vs -43.65% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 24.59% vs 11.62% in Sep 2025

Quarterly - Interest
Interest 3.31 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 271.91% vs -53.16% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 9.24% vs -14.65% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.70%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025